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Abstract
Most HIV-infected inmates leave prison with a suppressed viral load; many, however, become 
disconnected from care and non-adherent to medications during reentry to community life. In this 
secondary data analysis of focus groups (N = 6) and in-depth interviews (N = 9) with 46 formerly 
incarcerated HIV-infected people during reentry, we used an inductive analytic approach to 
explore the interplay between individual, interpersonal, community, and structural factors and 
HIV management. Participants described barriers and facilitators to care engagement and 
adherence at each of these 4 levels, as well as a milieu of HIV and incarceration-related stigma 
and discrimination. The constellation of barriers and facilitators created competing demands and a 
sense of chaos in participants’ lives, which led them to address reentry-related basic needs (e.g., 
housing, food) before health care needs. Interventions that simultaneously address multiple levels, 
including augmenting employment and housing opportunities, enhancing social support, and 
reducing stigma, are needed.
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In the United States, HIV prevalence among incarcerated persons is three to five times 
higher than that of the general population (Baillargeon et al., 2010; Westergaard, Spaulding, 
& Flanigan, 2013). Seventy-five percent of HIV-infected inmates begin treatment while 
incarcerated, and approximately 55% to 59% have suppressed viral loads upon release 
(Baillargeon et al., 2009; Stephenson et al., 2005). However, many HIV-infected inmates 
have difficulty sustaining adequate disease management during reentry. For example, in 
Texas only 5.4% of HIV-infected inmates filled prescriptions for antiretroviral therapy 
(ART) within 10 days of release, 17.7% within 30 days, and 30% within 60 days 
(Baillargeon et al, 2009). In other studies, only 20% to 54% of inmates enrolled in an HIV 
clinic within 1 month of release (Baillargeon et al., 2010; Wohl et al., 2011). Disruptions in 
care and poor adherence lead to higher HIV-related mortality, poorer HIV-related outcomes, 
and resistance to HIV medications in recently released individuals (Rosen, Schoenbach, & 
Wohl, 2008; Springer, Friedland, Doros, Pesanti, & Altice, 2007). Release from prison has 
been associated with an increase in viral load (Stephenson et al., 2005), which can result in 
ongoing HIV transmission if individuals engage in HIV-related risk behaviors (Rosen et al., 
2008; Springer et al., 2007). Understanding facilitators and barriers to linkage to HIV care 
and adherence to treatment post-release is critical for reducing HIV-related morbidity and 
mortality and preventing transmission within the communities to which these individuals 
return (Spaulding et al., 2009; Stephenson et al., 2005).
Several barriers and facilitators influencing access to care and medication adherence by 
formerly incarcerated HIV-infected individuals during reentry have been identified in the 
literature. Barriers identified in studies of former prisoners include strained interpersonal 
relationships (Baillargeon et al., 2009), return to impoverished neighborhoods (MacGowan 
et al., 2003), dual stigma of incarceration and HIV (Alexander, 2012), and inaccessibility of 
housing (Alexander, 2012; Baillargeon et al., 2009; Katzen, 2011; Stephenson et al, 2005), 
transportation (Katzen, 2011; Stephenson et al, 2005), insurance and employment 
(Alexander, 2012; Baillargeon et al. 2009; Katzen, 2011), as well as issues with mental 
illness and substance abuse (Springer, Azar, & Altice, 2011). Social support from case 
managers and personal motivation have been identified as facilitators that promote HIV 
management by improving ART adherence (Alexander, 2012; Katzen, 2011; Springer et al., 
2011; Woods, Lanza, Dyson, & Gordon, 2013). Although researchers have identified these 
barriers and facilitators, it remains poorly understood how these factors interact and 
influence each other and, ultimately, affect an individual’s success in adhering to HIV care. 
We examined the interplay of factors across these multiple levels and their impacts on 




We conducted a secondary analysis of formative, qualitative data, including in-depth 
interviews (IDI) and focus groups (FG) with formerly incarcerated men and women with 
HIV, collected to inform development of imPACT (Individuals Motivated to Participate and 
Adhere to Care and Treatment), a comprehensive intervention to help incarcerated people 
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with HIV engage in HIV care and adhere to ART after release (Golin et al., 2013). The 
institutional review boards at both The University of North Carolina at Chapel Hill and 
Texas Christian University approved all study procedures before study initiation.
Recruitment and Study Population
Recruitment fliers were displayed in HIV clinics, HIV outreach centers, and substance abuse 
treatment centers in order to passively recruit participants. Researchers also used database 
systems in HIV clinics to identify individuals who had previously provided consent to be 
contacted for participation in research studies. Our secondary data analysis included data 
from 12 female and 34 male, formerly incarcerated persons with HIV, residing in two states 
in the southern United States. At the time of the interviews, all participants were accessing 
HIV care. We summarized demographic features of all study participants in Table 1. Table 2 
lists demographic information for each IDI participant to illustrate the diversity of life 
experiences of the individuals in this study. FG participants shared demographic profiles 
similar to those participating in IDIs.
Data Collection
Two interviewers conducted six FGs (n = 37 participants across groups) and nine IDIs with 
individuals who were eligible but unable to attend an FG due to transportation challenges. 
Both IDI and FG guides focused on participant initiation of and attendance to clinic visits 
and adherence to ART recommendations. All data collection was conducted in private 
rooms at HIV clinics, HIV outreach centers, and substance abuse treatment centers from 
December of 2010 through May of 2011. Four IDIs were conducted over the phone. 
Participants received a 25 USD gift card for their participation. On average, IDIs lasted 
approximately 1 hour, and FGs were 2 hours. Researchers redacted all personal information 
and verified all IDI and FG transcripts from digital audio recordings.
Data Analysis
We used an inductive approach to conduct data analysis (Miles, Huberman, & Saldana, 
2014). Two researchers read all of the transcripts line-by-line and developed a matrix listing 
themes they identified in the transcripts. The researchers then developed a preliminary 
codebook consisting of topical codes based on questions from the interview guide (e.g., 
“medical care facilitators”) and inductive codes based on themes identified in the transcripts 
(e.g., “individual challenges”). The first author read all transcripts a second time to develop 
the final codebook and coded the transcripts using ATLAS.ti.v.7. The first author then 
drafted an analytical memo to summarize each code, which facilitated systematic 
identification of emergent themes in the data (Saldaña, 2012). During review of memos, we 
noticed that barriers and challenges occurred across multiple levels – individual, relational, 
structural – and decided the Social Ecological Framework (SEF) was an appropriate 
framework to guide additional analyses of the relationships of themes across these levels 
(Saldaña, 2012; Sallis, Owen, & Fisher 2008). We eventually chose to use the SEF to 
structure presentation of the findings because it fit well with our findings. The SEF was 
useful because it acknowledges that there are multiple levels of influence on behaviors 
(individual, interpersonal, organizational and community, and structural), and that these 
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levels of influence interact within and between each other to influence health outcomes 
(Sallis et al., 2008).
Steps were taken throughout this iterative analysis process to enhance study rigor and 
trustworthiness of findings (Lincoln & Guba, 1985). During the coding and analysis process, 
the research team discussed emergent ideas in bi-weekly meetings. Engaging multiple 
researchers with diverse training and understanding of the study population helped to reduce 
the influence of bias and enhance credibility of the findings (Shenton, 2004). Triangulation, 
in the form of inclusion of data collected via different methods from multiple sites and 
contextualization of emergent themes within the context of an existing theoretical 
framework, enhanced the transferability of the findings (Shenton 2004). Finally, the first 
author kept a detailed audit trail of analysis activities, emergent themes, and analytic memos 
throughout the process to ensure consistency in analysis processes and techniques across 
time (Morrow, 2005), steps which enhanced the dependability and confirmability of the 
results.
Results
We report results in four sections. In the first section, we describe individual experiences as 
prison staff made arrangements to connect participants to post-release care. Next, we 
describe post-release experiences that posed challenges for HIV management. Third, we 
describe perceived facilitators of HIV management post-release. We conclude by describing, 
in the fourth section, the overarching influence of stigma on participant transitions from 
prison to community. Throughout these sections, we present themes across the different 
levels of the SEF. The location of themes within different levels of the SEF is depicted in 
Figure 1. For each section of the results, we discuss how individual level factors may 
interact with factors at other levels to affect HIV-infected former prisoners’ access and 
adherence to care.
Connection to Care Before Release
Participant abilities to achieve continuity of care upon release were influenced by two major 
factors, one occurring at the individual and the other at the community level of the SEF: (a) 
Prior knowledge and experience, and (b) Institutional influence.
Individual level: Prior knowledge and experience—While incarcerated, individuals 
could rely on institutions to schedule examinations, fill prescriptions, and provide adherence 
support; upon release, they were responsible for their own HIV management. Those who 
received HIV care before incarceration more easily reconnected to care post-release, as 
explained by one man who had a provider before his incarceration: “I didn’t have a problem. 
Like I said, I think that my doctor was one of the first people I called, said, ‘I’m out.’ And 
she immediately made an appointment for me” (FG 2). Another man in FG 4 also asserted 
that his previous experience navigating the medical and insurance systems facilitated his 
ability to make an appointment with his preferred primary care provider:
You have to know how to maneuver around … they gave me a doctor, … but…I 
went in and change my PC (primary care provider), and called (insurance 
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company] … and said I wanted [physician’s name] for my PC doctor, went and 
signed some papers, this was prior to my appointment, this was a month and a half 
before my appointment because when I seen the little record thing and seen that 
they didn’t have her name on there, they won’t pay for it if it isn’t her name on it, 
so I started the ball rolling long before my appointment … (FG 4)
This individual was informed and preemptive; he knew to review his paperwork in advance 
of his first post-release appointment to ensure his ability to visit and pay for his preferred 
provider.
For others, navigating HIV care post-release was stressful and overwhelming. One man, 
who was diagnosed in prison, explained:
If you’re looking for a guy who’s been locked up 10 years but he’s been living with 
the virus and he’s been getting his medication, do you really expect him to come 
out here and function…? I mean, make appointments, take medication… (FG 1)
Determining the extent to which this participant’s challenges resulted from a limited 
understanding of how to navigate the medical system or a limited sense of agency due to 
prison staff managing his HIV care for several years is difficult. Additionally, navigating the 
medical system was a formidable barrier for individuals diagnosed while incarcerated 
because they lacked experience accessing HIV care in their communities.
Community level: Institutional influence—Although the pre-release procedures 
employed by jails and prisons vary across counties and states, almost all of our participants 
described policies designed to facilitate continuity of HIV management upon release. For 
those who received HIV care before incarceration, prison staff scheduled appointments for 
them with their former HIV providers. For those not previously connected to care, 
institutions made appointments at the local health department or a community health center. 
One man described the benefits of a system in which the prison sent records to the health 
department:
[The health department] do the examinations and they [the health department] do 
write off to the prison medical system and retrieve your records. So once your 
records come on the outside, they know what's going on with you while you were 
inside [prison]. (IDI 8)
Participants also received up to 1 month’s supply of HIV medications upon release (the 
exact amount varied by institution). Almost half of participants reported that obtaining an 
ART prescription from a community medical provider before that supply ran out was a key 
determinant of their adherence. Notably, several participants ran out of medications due to 
long wait times for appointments for HIV care. One woman recalled:
They did [give me a medicine supply to take home with me], but the [clinic name] 
said they couldn't get me in for what, about a month and a half, when I had got out 
… And I said, “I'll be done run out of medicine by then." (IDI 5)
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This participant requested and received additional medications from the nurse at the prison 
facility to prevent a lapse in adherence. Many others, however, were unable to see a provider 
despite their efforts, as described by one man:
I gave up for 3 years because I got tired of fighting the system to try to get them 
[medications], and I just said to heck with it. Three years I didn’t take them, and 
that’s just the way it is. (FG 4)
This quote reflected the strong influence of institutional factors, such as not being able to get 
appointments or medications, on care and treatment experiences post-release.
These examples reflected the interaction between community and individual level factors 
that affected connection to care. Specifically, the success of prison systems to facilitate 
continuity of HIV care post-release was contingent upon an individual’s ability to make and 
keep provider appointments before running out of medication as well as their previous 
knowledge and experience navigating the health care system.
Challenges to HIV Management During Reentry
Challenges participants experienced integrating back into their communities also hindered 
HIV management. From participant discussions of these challenges, we identified five 
subthemes across multiple levels of the SEF: (a) Substance use, (b) Housing, (c) 
Transportation, (d) Enrollment in insurance and safety net programs, and (e) Competing 
demands.
Individual level: Substance use—Several participants “partied” post-release, which 
involved drinking and illicit drug use. The reasons participants gave for partying included 
celebrating newfound freedom, reconnecting to social networks, or distracting oneself from 
the stresses of reentry. Some participants prioritized partying over HIV management and 
eventually lost motivation to access HIV care or adhere to their medications. One man 
recalled, “I stayed high all the time. I wasn’t thinking about taking ’em [medications]. And 
every time they make me an appointment, I would call and cancel it until the point I just 
stopped going and stopped taking medicine” (FG 2). Even when the HIV care system in the 
community tried to maintain contact with the patient, substance use was a strong deterrent to 
engagement in care. Other individuals intended to take their medications but forgot when 
intoxicated, as described by this male participant,
The difficult part came when I fell back into using drugs, okay? And I would forget 
all about taking the medication because I would be so high off the drugs that it 
would, you know, I would forget to take the doggone medication, you know. (FG 
3)
Some individuals did not adhere in the presence of those with whom they partied. One man 
confronted this challenge in his house where others gathered to use drugs,
I kinda’ didn’t take ’em because in my house, I stayed in a two-bedroom apartment, 
I had a bunch a people in getting high all the time. I didn’t want ’em to see what the 
pills were because, yeah, it got on there in the little writing, “HIV.” (FG 2)
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These individuals viewed the disease as stigmatizing and were wary of potentially disclosing 
their HIV status by taking medication in the presence of others. A few continued to access 
medical care while non-adherent, such as one woman from FG 2: Interviewer: “So you were 
still going into see her [the physician]?” Participant: “Yeah. And I told her, ‘I’m drinking. 
I’m smoking. I ain’t got time to take no medicines.’” Overtime, several individuals who 
partied experienced adverse health effects due to non-adherence or interactions between 
HIV medications and other substances.
Community level: Housing—Most individuals were released with few resources, into 
impoverished communities, and their incarceration histories limited housing options. One 
man described how homelessness made adherence a challenge: “Like I said, when you first 
get out, some of us don’t have nowhere to go, and you got nowhere to put your medicine” 
(FG 3). Homelessness also made it difficult for prisons to connect individuals to care before 
release, as one woman described, “If I had a stable residence that I was going to, so that way 
I could've had a set appointment already made for me [by the prison]” (IDI 5). Several 
participants disliked living in community shelters because limited privacy resulted in 
unintentional disclosure of serostatus. One man also expressed a fear that living in shelters 
could heighten his risk of becoming ill:
… when people do get out [of prison] with nothing, instead of putting them in these 
shelters, because that’s why I stay sick, when you’re around 250 people, and all of 
them are off the street, and they all come in there with all kinds of different things, 
God knows what, and your immune system is already low … (FG 4)
Participants faced both social and health risks due to limited housing options post-release 
that created barriers to adherence.
Community level: Transportation—For many participants, limited access to 
transportation significantly impeded both reentry and HIV management. One man released 
into an urban location described this challenge:
Yes [transportation] was an issue, it was a big issue, it was one of the number one 
issues … the main thing when I walked out of that door was, how do I get home, 
how do I get to this place, okay when I get to this place, I’ve got to go back here to 
get a referral to go back there, … coming out of the jailhouse, you have to get 
home, and then you have to get to these [other places], because when they let you 
out, it’s not at 8 a.m. in the morning when everything is open right around the 
corner. (FG 6)
Many returned to communities far from an HIV clinic, and those without access to 
transportation faced difficulty accessing medical care. One man recalled, “So my problem 
was getting someone to take me up to [city name, for clinic appointments] which is nearly a 
hundred miles away” (IDI 8). Thus, participants missed appointments or received care from 
local clinicians who may not have previously seen them. While transportation was a barrier 
to accessing medical care, some participants received transportation support from case 
managers, as illustrated below.
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Structural level: Lack of enrollment in insurance and safety net programs—For 
several individuals, lacking health insurance or financial assistance created an obstacle to 
accessing HIV medications or medical care, as demonstrated by this exchange.
Interviewer: Yeah, so what’s the major obstacle for you seeing a doctor?
Participant: They’re worried about money…
Interviewer: It’s money….
Participant: It’s money, it’s insurance, and I have none, I have nothing, because like 
I said, when I stepped out [of prison], I [had] lost everything I had. (FG 4)
A few individuals suggested that having health insurance or financial assistance would 
enable them to access higher quality care. Further, participants found HIV management 
difficult when they lacked housing, food, or employment. Safety net programs, such as 
Medicaid, or those offering supplemental income or food assistance, were a critical source 
of support for this population. Other sources of support included multiple clinics and HIV 
Outreach Service Providers offering case management, transportation assistance, housing 
assistance, and mental health services, but the availability of such services varied 
substantially from county to county, with some, often more urban, counties having more 
services available. Several participants, however, experienced what felt like burdensome 
paperwork and “red tape” (IDI 1), “had to fight” (IDI 4), or applied several times to enroll in 
these programs. Individuals also described restrictions (e.g., not living with their children) 
that resulted in rejected applications; however, other unnamed factors, such as low health 
literacy, may have also influenced participants’ experiences. Challenges enrolling in 
programs reduced access to medical care, as described by one man who disengaged from 
care for 4 years post release:
If I’d have got Medicaid I would have went ahead through with [seeing a 
physician], but they did not – there was – they told me there was no way I could – 
there was two ways I could get Medicaid, either my kids are staying with me in the 
same household or I’m disabled. (IDI 1)
He further explained that he felt he had to choose between not working or receiving other 
financial support, which would enable him to qualify financially for Medicaid but prevent 
him from earning an income for his non-medical needs:
So my thing is I don’t want to just sit around that house not doing nothing when I 
could be out at least trying to work because, you know, I have to [buy] hygiene 
items for myself, toothpaste, lotion, deodorant, and I can’t get that because in order 
for me to get Medicaid or food stamps, first thing they ask me is, “Are you 
receiving any money from anybody?” And if I say my father gives me money, then 
they was going to deny it. So it’s like a no-win situation. (IDI 1)
Because they were unable to enroll in health insurance or safety net programs, some 
participants felt they had to choose between caring for their health or meeting other basic 
needs.
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Structural level: Competing demands—Participants explicitly described facing 
competing demands between HIV management and needs related to reentry; many felt 
overwhelmed. One participant described the situation: “In other words, in prison you’re in a 
controlled environment. They let you out, you’re in a world of chaos, no transportation, no 
meds, no home, no phone, just go” (FG 4). Several individuals focused on finding housing, 
work, or reestablishing relationships with family and friends, which distracted them from 
taking HIV medications. One man reflected, “So I’d say the hardest part is remembering 
every single day. ‘Cause now I’m out in the world; I’m trying to find a job. I’m running 
around. I’m doing this and this and it’s like I can sometimes forget” (IDI 9). Despite valuing 
his health, the stress of managing other aspects of his life made it difficult to focus on 
adherence. Some participants chose not to adhere because side effects adversely affected the 
ability to meet other responsibilities, as exemplified by one male participant: “I[‘m] a 
supervisor of a group home on the weekends under the table, of course. And I don’t take my 
medication while I’m at work because I don’t wanna’ be drowsy or whatever” (FG 2).
These experiences suggest that when individuals experienced the competing demands of 
HIV management and attending to reentry-related needs, they often met reentry needs first. 
Altogether, several of the barriers to reentry experienced by former inmates occurred within 
their communities or were structural and, for those who also experienced individual level 
challenges with substance use, the ability to overcome structural and community-level 
barriers while managing HIV was further complicated.
Facilitators to HIV Management During Reentry
In addition to these challenges, participants also described experiences that supported HIV 
management post-release. We identified three key facilitators: (a) Focusing on HIV 
management, (b) Support from individuals, and (c) Support from community programs and 
organizations, each occurring at a different level of the SEF.
Individual level: Focusing on HIV management—Several participants emphasized 
personal responsibility for their health and focusing on HIV management as facilitators to 
HIV management and overcoming reentry-related challenges, as illustrated in this exchange: 
Interviewer: “Was there anything hard about keeping doctors’ appointments for your HIV 
care?” Participant 5: “No, you gotta’ stay on top of it, I do.” Participant 1: “It’s where your 
priorities are at” (FG 5). For a few, the experience of incarceration motivated prioritization 
of HIV management upon release, as described by one man, “So I was like I need to keep 
doing what – doing the things to my body that the prison was doing for me as far as keeping 
me, I guess, healthy and keeping my immune system infection-free” (IDI 6). His motivation 
to maintain his health prompted him to seek medical care when he was first released from 
prison and to take his medications at the same time he received them while incarcerated to 
prevent missing a dose. Other participants focused on HIV management because they valued 
their lives. These sentiments seemed particularly strong among female participants, for 
example:
Interviewer: … What prompted you to go see [the physician]?
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Participant: I had to get my refill. That’s my life right there. I have to live. I take 
my medication, two pills, every night with some kind of food so that I make sure I 
don’t get sick to my stomach or get diarrhea or stuff like that. I take my medication. 
(FG 1)
As previously described, individuals experienced several barriers to adherence and accessing 
care upon release; these experiences, however, illustrated that internal motivation and 
focusing on health facilitated adherence and access to care by providing individuals with the 
drive needed to overcome some community and structural barriers to HIV management.
Interpersonal level: Support from individuals—Almost half of our participants 
received tangible support from others, including family, friends, and neighbors. Several 
participants received reminders from family members, roommates, or significant others, 
which helped them adhere to ART. One man described interactions with his fiancé, “My 
fiancé calls me, she says, ‘It’s time to take your medicine.’ I go, ‘Okay thank you,’ and I get 
on up” (IDI 4). Another participant recalled support from his neighbor and family when he 
became extremely ill:
I got sick, and my neighbor lady at this little apartment complex I lived in got my 
emergency number out of my wallet who called my sister here, who called my 
sister in [state], who called the hospital I was in … She talked to the hospital and 
they said ‘yeah, he’s this, this, this, and that’…. after I got out of the hospital, I left 
[state] to live with her, when I got off the plane, she had found four AIDS doctors 
within 25 miles of her house, that she could take me to or have United Way do it. 
(FG 4)
The experiences described above demonstrated how support from others could increase 
adherence and save lives.
Community level: Support from community programs and organizations—A 
few participants participated in ART adherence programs or substance abuse recovery 
programs in their communities, which facilitated adherence by helping them build HIV 
management skills, overcome addiction, and find peer support. One man explained,
First it started out where we had just a men’s group where we called each other 
and, “You take your medicine? You take your medicine?” We had a little buddy 
system ask, “You take your medicine today?” and it helped a lot that somebody 
else was concerned to ask me. (FG 2)
In addition to serving as a reminder, peer support cultivated in recovery groups helped 
participants feel like someone else cared about them and their livelihoods, which in turn, 
helped maintain motivation to adhere to their medications.
Some individuals received services through community organizations and institutions that 
facilitated access to medical care. Participants seemed to rely heavily on the local health 
department for care, and several described positive interactions with the providers, which 
helped them stay engaged. Some received charity care through local hospitals or through 
participation in research studies. Case managers, rehabilitation center staff, and home health 
Dennis et al. Page 10













providers were other important sources of support. Several participants received help from 
these individuals to find housing and transportation, schedule provider appointments, and 
enroll in safety net programs. One man described: “[Name] makes sure I was able to make 
the appointments here. She’s a health care home provider and I called her today to get me an 
appointment and she makes all of my rides and they pay for everything” (FG 3). Another 
participant received case management for his reentry needs: “Yeah because there are a lot, 
see there are other benefits to going to [agency name], there’s a lady there that gives you 
clothes and bus vouchers, and referrals and things, and these are things you need…” (FG 5). 
Some participants who used case management before incarceration resumed it upon release. 
Others received instructions from prison facilities upon release to retain case management 
for assistance connecting to HIV care. Notably, some reported difficulty initiating services 
due to high agency caseloads and burdensome paperwork required to receive services.
Participants also took advantage of federal programs specifically for people with HIV that 
helped them meet their reentry-related needs. One participant enrolled in a program enabling 
her to find a nice apartment:
But my apartment I found was on the higher end of what they typically pay. But if 
you find an apartment within that range, they could potentially pay your rent and all 
your utilities. The only contingency is you must be HIV-positive. It’s through the 
Ryan White Act. (IDI 2)
She later described how support from this program in finding a secure, stable place to live 
ultimately provided her a safe location to store her medications and take them in private.
Stigma, a pervasive influence—In addition to the previously described barriers and 
facilitators that fell within the different levels of the SEF, one overarching barrier that cut 
across levels was stigma. At the interpersonal level, some participants’ family members 
made them feel inferior by using their serostatus or incarceration histories as weapons in 
arguments. Stigma experienced at the interpersonal level also made it difficult to find 
housing, as described by one man:
Well, I got tired of sleeping in my car; I got tired of going places and people 
turning me down because of the fact that they knew that I was HIV positive. Even 
my own mother was weary of me and she would be like, “You can’t stay here.” 
And when she gave me something to drink it was in a plastic cup and paper plates. 
And, “Don’t sit here in this chair, you sit over there,” and all this kind of stuff. (FG 
1).
Experiences with stigma strained participants’ interpersonal relationships and made them 
wary of disclosure, which limited opportunities to receive social support. Furthermore, 
stigma experienced at the interpersonal-level interfered with HIV management for those 
who felt judged by medical providers for being formerly incarcerated and HIV infected. One 
man explained, “I don’t like really having to explain myself and the reasons why and then 
him [the physician] giving me the side look like I was like trash almost or disposable or 
‘You’re one of those patients’” (FG 2). In several cases, experiencing stigma made 
individuals reluctant to interact with their providers in the future, and anticipating stigma 
from providers resulted in missed appointments, as described by another man:
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My first doctor, I hated her because she had accused me of – one of my neighbors 
was mad with me, so they [the neighbor, called my doctor and told her] that I was 
abusing my life partner. And [my doctor] came out and asked me and I told her, 
“No. All I did was drink and stuff. And I had never touched anyone.” And then she 
[the physician] kept running and going on that, “If you try to hide it… I’ll have the 
police – have you evicted.” And so I hated her [the physician]. So I would not go to 
the doctor because I didn’t want to deal with her. (FG 2)
This participant’s interactions with his provider made him feel stigmatized, which kept him 
from returning to HIV care. Patient-provider dynamics were especially influential for those 
lacking health insurance because their options for choosing another provider were limited.
Within their communities, participants were stigmatized due to their incarceration histories, 
which adversely affected the ability to meet needs related to reentry. One man described his 
experience looking for work:
And the two jobs that I’m qualified for, they turned me down. They turned me 
down talkin’ about, “You’ve got a felony on your record.” But yet the two people 
that they hired for the job, neither one of them stayed there 30 days. But I had the 
experience that they didn’t have. But you wouldn’t hire me because I’ve got a 
record. (FG 3)
At the structural level, participants described policies prohibiting former prisoners from 
applying for needed support. One man lamented the difficulty of expunging his record for a 
fresh start, “So I’m just sorta’ in the pipeline now. They say you need to have the felony 
removed, but nothing’s never removed” (FG 2). Another man attributed high recidivism 
rates in formerly incarcerated persons to structural discrimination and stigma within his 
community:
I’m a G-grade felon, I can’t never get food again; can’t never get food stamps. And 
they be trying to figure out what keeps people going back to prison. If you can’t 
never get food stamps, and ain’t too many gonna’ hire you if you commit a felony. 
… And you might just be dealing with a misdemeanor but it doesn’t matter; they 
don’t want you around, ‘cause they scared of you. (FG 3)
Participants in our study often met reentry-related needs before focusing on HIV 
management. Societal stigma and resulting discrimination heightened existing barriers of 
competing demands to meet reentry-related needs and delayed participants’ abilities to 
achieve the stability necessary to turn their attention to HIV management. This was 
especially true for participants who lacked support from others to help them overcome 
barriers and connect to resources. A few participants described peers who desired to return 
to prison because the barriers to reentry and HIV management were too difficult to 
overcome.
Discussion
We explored the interactions between factors influencing engagement in care and adherence 
in formerly incarcerated men and women with HIV through the lens of the SEF. The degree 
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to which participants could meet both their HIV management and reintegration needs varied 
and, often, structural and community level factors largely beyond their control substantially 
hindered or aided the ability to manage the virus. The majority of individuals faced 
challenges connecting to care during reentry despite prisons having relatively strong systems 
in place to link individuals to HIV care post-release. Those who had some individual or 
interpersonal level support, including previous experience, a devoted case manager, or a 
strong internal drive to manage their HIV, generally experienced fewer challenges. Upon 
release, participants experienced many competing demands, and their experiences of 
interactions between the barriers and facilitators across multiple levels influencing these 
demands made their lives feel chaotic. Some participants were both motivated to conduct 
HIV management and had the support and resources necessary to act on these motivations. 
Others wanted to manage their HIV but faced barriers across different levels of the SEF, 
such as addiction (individual level; Springer et al., 2007) or lack of housing and 
transportation (community level; Alexander, 2012; Katzen, 2011; Stephenson et al, 2005), 
which interfered with disease management, findings consistent from research on 
underserved HIV-infected populations who cycled in and out of HIV care (Parker & 
Aggleton 2003). We also found that some participants lacked the social support and 
resources to both successfully reenter society and manage their HIV. Overarching all of 
these experiences was a context of stigma related to both HIV and incarceration, which also 
served as a barrier to care and adherence. Our study design (with mixed gender focus 
groups) did not allow exploration of gender differences in reentry experiences, however, 
given the vast literature describing differences in health care seeking behaviors between 
women and men (Galdas, Cheater, & Marshall, 2005), this topic may warrant future 
research.
One of the most salient structural level barriers to care and treatment was the inability to 
enroll in health insurance and federal safety net programs during reentry, which limited 
access to quality health care in our sample, findings which support prior research 
(Baillargeon et al, 2009; Katzen 2011). This barrier was complicated at the individual level 
by participants who anticipated experiencing stigma from health care providers, which 
further reduced access to quality care. These findings suggest the importance of providing 
formerly incarcerated HIV-infected individuals with education and support to facilitate self-
advocacy and successful navigation of the medical system. In addition, providing sensitivity 
training for health care providers working with this population may be useful. Nationally, 
about one third of prisons do not provide Medicaid enrollment support prior to release 
(Rosen et al., 2014). Providing HIV-infected inmates with support to enroll in Medicaid 
(Teitelbaum & Hoffman, 2013) before release would facilitate continuity of care after 
release, as well as provide individuals with the ability to find providers who meet their 
needs.
The Patient Protection and Affordable Care Act (ACA) provides several structural level 
opportunities to increase access to and quality of care. Under the ACA, up to 57% of 
inmates released annually would be eligible to enroll in Medicaid or receive federal tax 
credits to help purchase insurance through state and federal health insurance exchanges 
(Cuellar & Cheema, 2012). Formerly incarcerated people with HIV, however, will only 
benefit from these opportunities if they purchase insurance through exchanges or reside in a 
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state that has expanded Medicaid. Data collection for our study took place prior to passage 
of the ACA; because our participants resided in the U.S. southeast, a region where only 1 
state (Arkansas) of 11 has chosen to expand Medicaid (The Henry J. Kaiser Family 
Foundation, 2014), most will not benefit from Medicaid expansion. However, provisions in 
the law providing substance abuse counseling, increasing funding for mental health home 
care visits, expanding reliance on use of medical homes, and providing incentives to 
increase the use of electronic medical records should increase the quality of health care 
accessed by this vulnerable population, regardless of state residence (Teitelbaum & 
Hoffman, 2013).
While we did not identify a “magic bullet” that seamlessly kept individuals adherent and in 
care post release, social support, through institutions and personal networks, was 
instrumental in helping HIV-infected individuals manage their disease and the reentry 
process, a finding supported by the literature (Alexander, 2012; Katzen, 2011; Woods et al., 
2013). These findings underscored the importance of (a) connecting HIV-infected inmates to 
resources to address reentry needs, such as housing, employment, and substance abuse 
treatment, and (b) reinforcing social support systems prior to release, to facilitate continuity 
of care post release. Community organizations offering disease management programs and 
resources to help individuals access medical care were also crucial. These findings provide 
evidence for the usefulness of community-based reentry models that address several levels 
of the SEF by integrating case management, community support, health care, and access to 
employment, transportation, and substance abuse resources for this population (Woods et al., 
2013).
Finally, many participants described a heavy burden of incarceration-related stigma and 
some recalled experiences with HIV-related stigma. Experiencing HIV- or incarceration-
related stigma heightened barriers to reentry by making it more difficult for participants to 
meet needs related to securing housing and employment. Striving to overcome these 
heightened barriers delayed participants’ abilities to turn their attention toward establishing 
care with a trusted provider and interfered with the ability to adhere to a medication 
schedule. These findings were consistent with existing theories that describe both 
anticipated and enacted stigma experienced by HIV-infected individuals (Earnshaw & 
Chaudoir, 2009; Parker & Aggleton, 2003) and provide support for implementation of 
interventions focused on reduction of HIV-related stigma within communities (Sengupta, 
Banks, Jonas, Miles, & Smith, 2011), as well as the development of interventions to reduce 
stigma due to incarceration at the community and structural levels. Further, it is likely that 
some participants in our study experienced an enhanced burden during reentry due to the 
compounded effects of HIV- and incarceration-related stigma (Reidpath & Chan, 2005); 
however, the extent to which participants experienced layered stigma was not discernible 
from these data and merits exploration in future studies.
This study has limitations. The experiences reported here may not reflect the experiences of 
formerly incarcerated people with HIV who never engaged in care post-release, as all 
participants were enrolled in HIV treatment at the time of this study. Participants may have 
provided socially desirable responses, as it was known that the interviewers were developing 
an intervention to support access to HIV care. Furthermore, some participant responses may 
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have been colored by recall bias, as the length of time since last incarceration was long for 
some participants. Despite these limitations, the findings give care providers, researchers, 
community practitioners, and policy-makers rich information that could be used to develop 
interventions to help formerly incarcerated people with HIV improve HIV management post 
release.
Conclusion
HIV-infected inmates facing prison release experienced competing needs between HIV 
management and meeting reentry needs, and they often first met reentry related needs. 
Those with resources, including social support and experience with navigating care systems, 
were more easily able to overcome individual and contextual barriers to HIV management. 
Structurally, the ACA provides opportunities to help this population access quality health 
care. Interventions seeking to augment social support amongst family and friends of 
formerly incarcerated HIV-infected individuals and reduce HIV- and incarceration-related 
stigma in HIV care providers and potential employers and landlords, should facilitate 
continuity of care for this population.
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• Most HIV-infected inmates leave prison with a suppressed viral load; many, 
however, become disconnected from care and non-adherent to medications 
during reentry to community life.
• HIV-infected inmates facing prison release experienced a sense of chaos in their 
lives due to competing needs between HIV management and meeting needs 
related to reentry (e.g., housing, food), and they often worked on reentry-related 
needs first.
• Barriers and facilitators affecting HIV management occurred at individual, 
interpersonal, community, and structural levels.
• HIV-infected inmates facing prison release, who possessed resources, including 
social support and prior experience navigating health care systems, were more 
easily able to overcome individual and contextual barriers to HIV management.
• Interventions that simultaneously address multiple levels, including augmenting 
employment and housing opportunities, enhancing social support, and reducing 
stigma are needed to facilitate continuity of care within this population.
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Factors influencing ART Adherence and engagement in care across the Social Ecological 
Framework.
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Table 1
Demographics of Sample at Time of Interview
Characteristic n = 46 (%)
Race/Ethnicity
  Black 39 (84.8%)
  White 4 (8.7%)
  Hispanic/Latino 1 (2.2%)
  Multiracial 2 (4.3%)
aAverage Age in Years 43
  Range 23 – 60
Education Level
  Did not complete high school 6 (13.0%)
  High school diploma or earned GED 16 (34.8%)
  Some college or earned bachelor’s degree 20 (43.5%)
  Some graduate school or earned graduate degree 4 (8.7%)
aAverage Number of Incarcerations 3
  Range 1 – 8
Length of Last Incarceration in Years
  < 1 21 (45.7%)
  1 – 3 10 (21.7%)
  4 – 5 2 (4.3%)
  6 – 10 5 (10.9%)
  11 – 20 2 (4.3%)
  ≥ 21 1 (2.1%)
  Missing 5 (10.9%)
Employment Status
  Unemployed with disability 18 (39.1%)
  Unemployed without disability 11 (23.9%)
  Worked part-time 2 (4.3%)
  Worked full time 2 (4.3%)
  Retired 1 (2.2%)
  Missing 12 (26.0%)
Relationship Status
  Single 22 (47.8%)
  Married 4 (8.7%)
  Separated 2 (4.3%)
  Divorced 6 (13.0%)
  Widowed 1 (2.2%)
  Missing 11 (23.9%)
a
Data for participants’ ages and number of incarcerations were missing for 2 participants; averages were calculated at n = 44.
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